CEL SCI CORP

CVM

CEL SCI CORP

CVM

Insider Sentiment (TTM):

Last Purchase:2026-05-14Last Sale:-Shares Purchased (TTM):446,412Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:746,090Shares Outstanding:8,492,777Institutional Ownership Pct.:8.78%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	7	2	6	11	2	2	5	5	0	5	3	4
Prepaid Expense Current	1	1	1	0	0	0	0	0	1	1	1	1
Inventory Net	-	-	-	-	-	-	-	1	-	-	2	2
Deposits Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	8	3	7	12	3	3	6	6	4	9	6	7
Finance Lease Right Of Use Asset	-	5	5	6	6	6	7	7	8	8	9	9
Operating Lease Right Of Use Asset	1	1	2	1	1	1	1	1	2	2	2	2
Property Plant And Equipment Net	5	5	6	6	7	7	8	8	9	9	10	10
Finite Lived Intangible Assets Net	0	0	0	0	0	0	0	0	0	0	0	0
Deposits Assets	-	-	-	-	-	-	-	-	-	2	2	-
Deposits Assets Noncurrent	2	2	2	2	2	2	2	2	2	-	-	2
Inventory Noncurrent	-	-	-	-	-	-	-	1	-	-	-	0
Assets	21	18	23	28	20	22	26	27	24	30	29	31
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	2	2	2	1	1	1	1	2
Accrued Liabilities Current	0	0	0	1	0	1	1	1	1	1	1	1
Finance Lease Liability Current	-	2	2	2	2	2	2	2	2	2	2	2
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	5	5	5	5	6	5	5	5	6	5	5	6
Finance Lease Liability Noncurrent	-	4	5	6	6	7	7	8	8	9	9	10
Operating Lease Liability Noncurrent	1	1	2	1	1	1	1	1	1	2	2	2
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	10	11	12	12	13	14	14	14	16	16	16	17
Commitments And Contingen…
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	1	1	0	1	1	1	0
Additional Paid In Capital	567	557	556	555	540	535	532	527	516	515	506	500
Retained Earnings Accumulated Deficit	-556	-550	-545	-539	-533	-528	-521	-514	-508	-501	-494	-487
Stockholders Equity	11	7	11	16	7	8	11	13	8	14	13	13
Liabilities And Stockholders Equity	21	18	23	28	20	22	26	27	24	30	29	31
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	600	600	600	600	600	600	600	600	600	600	600	600
Common Stock Shares Issued	18	8	8	8	5	3	2	2	2	2	2	2
Shares Outstanding	18	8	8	8	5	3	2	2	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-25.31%	-14.85%	-64.44%	-4.20%	-20.28%	-14.69%	-	-	-	-	-	-
2025	-16.67%	-47.62%	-40.48%	-66.94%	-65.42%	31.25%	28.87%	28.62%	-12.90%	12.33%	-7.51%	-33.72%
2024	-3.78%	-25.63%	-31.51%	-9.72%	-15.97%	-20.14%	-6.96%	-6.09%	-24.35%	-7.32%	-14.63%	-46.34%
2023	-	-	-	-	-	-	-	-	-	-3.37%	-7.87%	-14.23%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.48	0.60	1.39	2.26	0.47	0.55	1.07	1.31	0.64	1.67	1.26	1.24
Quick Ratio	1.34	0.45	1.29	2.20	0.41	0.51	1.00	1.03	0.54	1.54	0.67	0.74
Working Capital	2.42M	-1.91M	1.99M	6.47M	-2.99M	-2.48M	378.23K	1.44M	-1.96M	3.42M	1.29M	1.33M
Leverage & Debt
Debt to Equity	0.95	1.58	1.06	0.76	1.89	1.73	1.27	1.10	1.84	1.10	1.27	1.31
Interest Coverage TTM	-50.19	-43.92	-41.09	-38.23	-35.82	-36.54	-37.27	-35.34	-48.50	-51.97	-56.30	-63.78
Debt Ratio	0.49	0.61	0.51	0.43	0.65	0.63	0.56	0.52	0.65	0.52	0.56	0.57
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.87	-2.79	-2.97	0.59	0.57	0.18	-0.07	-15.31	-16.26	-17.38	-19.33	-21.83
Free Cash Flow Per Share TTM	-0.95	-1.96	-2.02	-2.14	-3.25	-6.40	-7.36	-8.90	-10.59	-11.33	-14.07	-14.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-1,057.21%	-4,460.88%	15,568.36%	-108.63%	-108.10%	-101.73%	-99.51%	-14.72%	-10.50%	-876.81%	-1,403.10%	-2,307.61%
EPS Growth (1Y)	-389.60%	-1,542.29%	4,490.93%	-102.29%	-102.75%	-101.11%	-99.67%	-36.68%	-26.19%	-728.93%	-1,231.72%	-2,108.68%
Valuation Metrics
P/E TTM	-0.81	-1.20	-1.86	30.98	5.14	37.23	-194.83	-2.45	-2.15	-3.43	-4.36	-1.83
P/B TTM	1.67	3.97	3.98	4.62	1.73	2.42	2.62	5.26	7.42	7.21	10.74	4.48
Market Cap	18.29M	27.26M	44.29M	73.74M	12.19M	19.38M	29.60M	67.63M	62.88M	103.20M	135.91M	59.22M
Enterprise Value	11.76M	32.22M	45.42M	79.08M	18.87M	26.44M	34.48M	72.86M	72.92M	108.76M	143.97M	66.79M
Calculated Values
Free Cash Flow TTM	-16.75M	-16.66M	-17.01M	-17.16M	-17.32M	-17.98M	-18.15M	-18.92M	-19.14M	-20.40M	-23.44M	-23.22M
Net Debt	-6.53M	4.96M	1.13M	5.34M	6.68M	7.06M	4.87M	5.23M	10.04M	5.57M	8.05M	7.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-14Purchase

Owner: Kersten, Geert R

Title: Chief Executive Officer

Shares: 300,000

Price/Share: $1.20

Value: $360,000.00

Shares Owned: 311,547

Relationship: Director,Officer

Ownership: Indirect

2026-05-13Purchase

Owner: Kersten, Geert R

Title: Chief Executive Officer

Shares: 100,000

Price/Share: $1.19

Value: $119,000.00

Shares Owned: 222,497

Relationship: Director,Officer

Ownership: Direct

2026-01-22Purchase

Owner: Kersten, Geert R

Title: Chief Executive Officer

Shares: 38,023

Price/Share: $5.26

Value: $200,000.98

Shares Owned: 120,815

Relationship: Director,Officer

Ownership: Direct

2025-12-04Purchase

Owner: Kersten, Geert R

Title: Chief Executive Officer

Shares: 8,389

Price/Share: $5.96

Value: $49,998.44

Shares Owned: 81,794

Relationship: Director,Officer

Ownership: Direct

2025-07-25Purchase

Owner: Watson, Robert Eugene

Title: -

Shares: 2,919

Price/Share: $6.85

Value: $19,995.15

Shares Owned: 3,733

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-14	Kersten, Geert R	Director,Officer	Chief Executive Officer	Indirect	Purchase	300,000	1.20	$360,000.00	311,547	4
2026-05-13	Kersten, Geert R	Director,Officer	Chief Executive Officer	Direct	Purchase	100,000	1.19	$119,000.00	222,497	4
2026-01-22	Kersten, Geert R	Director,Officer	Chief Executive Officer	Direct	Purchase	38,023	5.26	$200,000.98	120,815	4
2025-12-04	Kersten, Geert R	Director,Officer	Chief Executive Officer	Direct	Purchase	8,389	5.96	$49,998.44	81,794	4
2025-07-25	Watson, Robert Eugene	Director	-	Direct	Purchase	2,919	6.85	$19,995.15	3,733	4
2025-07-25	Kersten, Geert R	Director,Officer	Chief Executive Officer	Direct	Purchase	29,197	6.85	$199,999.45	72,835	4
2024-05-08	Prichep, Patricia B	Officer	Senior Vice President	Direct	Purchase	8,000	1.39	$11,120.00	232,326	4
2024-05-08	Watson, Robert Eugene	Director	-	Direct	Purchase	20,000	1.39	$27,800.00	24,431	4
2024-05-08	Kersten, Geert R	Director,Officer	Chief Executive Officer	Direct	Purchase	30,000	1.39	$41,700.00	1,195,309	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

8.78%

Inst. Shares: 746,090

Shares Outstanding: 8,492,777

2025-12-31

8.68%

Inst. Shares: 730,618

Shares Outstanding: 8,419,610

2025-09-30

8.69%

Inst. Shares: 696,475

Shares Outstanding: 8,015,701

2025-06-30

14.38%

Inst. Shares: 764,959

Shares Outstanding: 5,321,341

2025-03-31

253.87%

Inst. Shares: 7,130,774

Shares Outstanding: 2,808,847

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	746,090	8,492,777	8.78%
2025-12-31	730,618	8,419,610	8.68%
2025-09-30	696,475	8,015,701	8.69%
2025-06-30	764,959	5,321,341	14.38%
2025-03-31	7,130,774	2,808,847	253.87%
2024-12-31	6,503,776	2,466,999	263.63%
2024-09-30	5,651,927	2,126,682	265.76%
2024-06-30	5,914,157	1,806,788	-
2024-03-31	7,154,589	1,800,988	-
2023-12-31	6,187,178	1,665,619	-
2023-09-30	5,159,654	1,579,163	-
2023-06-30	5,201,966	1,490,123	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CEL SCI CORP (CVM) — SEC Financial Statements & Analysis

CEL SCI CORP (CVM) is a biological products, (no diagnostic substances) company, incorporated in CO. CEL SCI CORP trades on NYSE as: CVM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CEL SCI CORP reported a Debt-to-Equity ratio of 0.95x, a Price-to-Book (P/B) ratio of 1.67x (TTM), at a market cap of $18.29M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.95x
P/B TTM: 1.67x
Market Cap: $18.29M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CEL SCI CORP in?

CEL SCI CORP (CVM) operates in the Biological Products, (No Diagnostic Substances) industry.

What is CVM's market cap?

CEL SCI CORP (CVM) has a market capitalization of $18.29M as of 2026-06-30.

What exchange does CVM trade on?

CEL SCI CORP (CVM) trades on the NYSE.

Where is CEL SCI CORP incorporated?

CEL SCI CORP is incorporated in CO.

CEL SCI CORP

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

CEL SCI CORP (CVM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

CEL SCI CORP (CVM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.